Insulin Flashcards
1
Q
How can the insulin be stimulated?
A
- High blood glocose
- GI hormone ( e.g. gastrin, cholecstokinin, gastric inhibitory peptide/ GIP, glucagon like peptite/GLP)
- OTHER stimuli, ( amino acid, fatty acid, the parasympathetic nervous system)
- Beta sympathetic nervous system
2
Q
How do insulin be excreted from body ?
A
1 liver <60%>
2. Kidney 35-40%
3
Q
The action of insulin:
A
- Increase insulin uptake for utilisation( glycolysis)
- Glycogen synthesis (glucose to glycogen in liver)
3 . Protein synthesis - Lipogenesis
- Inhibit glycogenolysis (glycogen–> glucose) and glyconeogenesis
- Decrease proteim breakdown and inhibit oxidation of amino acids in the livee
- Transport into cells of K, Ca, necleosides and inorganic phosphate
4
Q
Metformin, actions include:
A
- Increase insulin sensitivity
- Direct stimulation of glycolysis in tissues, with increased glucose removal from blood
- Reduce hepatic and renal gluconeogenesis
- Slowing the glucose absorptiom from the GIT
- Reduction of plasma glucagon levels
Targeting the fasting glucose with high efficacy
5
Q
Properties of metformin
A
- Not bound to plasma protein
- Not metabolism
- Is excreted by the kidneys as the active compound
6
Q
What are the aderse effects of metformin?
A
- Anorexia ( LOA), N/V, abdominal distension and diarrhoea ( to take with food, GI S/E may improve after 1 to 2 mths of treatment
- Reduced absorption of Vit B12
- May need to monitor Cr ( high Cr may leads to metformin build up in the body, leading to metfamin acidosis)
7
Q
Metformin is contraindicated for:
A
- Renal disease
- Alcoholism
- Hepatic disease
- Or conditions predisposing to tissue anoxia
8
Q
MOA of sulfonylurea:
A
sulphonylurea receptor coassembles with the Kir subunit in a 4:4 steichiometry to form an actameric channel complex.
This complex forms the ATP-sensitive K+ (Katp] channel.
Both subunits must be coexpressed to obtain functional channel activity.
Action:
1. Increase insulim release from Pancreatic B cells
2. Reduction of serum glucogon concentrations
9
Q
S/e of sulfonylureas
A
- Hypoglycemia
- Weight gain
- GI upset
- Allergic skin rashes, bone marrow damage
- Increase in cardiovascular death